MLchartDataset catalogue

Tiazofurin

Term · Oncology and biomedicine · MLC-T-ONC-008706

  1. An anticancer drug being studied to stop cell growth.

  2. A synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis. Inhibition of IMPDH results in reduced levels of guanylates, resulting in the inhibition tumor cell growth in vitro and in vivo.

Table 1. Record
IdentifierMLC-T-ONC-008706
FieldOncology and biomedicine
AbbreviationTCAR
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-008706",
  "term": "Tiazofurin",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An anticancer drug being studied to stop cell growth.",
    "A synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis. Inhibition of IMPDH results in reduced levels of guanylates, resulting in the inhibition tumor cell growth in vitro and in vivo."
  ],
  "abbreviation": "TCAR",
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tiazofurin/"
}

Record 16,350 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.